Omicron BQ, XBB subvariants are a serious threat to boosters and knock out antibody treatments, study finds
The omicron subvariants that have become dominant in recent months present a serious threat to the effectiveness of the new boosters, render antibody treatments ineffective and could cause a surge of breakthrough infections, according to a new study.